Posted by Michael Wonder on 21 Jan 2023
Novartis warns US plan to curb drug prices could hit key research
21 January 2023 - US Government plans to rein in drug prices could discourage work in some of Novartis' most promising areas of research, the Swiss drug maker warned on Friday, urging Washington to rethink the "unintended" effects of its new rules.
US President Joe Biden in August signed into law the Inflation Reduction Act, which allows the federal Medicare scheme to negotiate prices on some of its most costly drugs.
